Delivery Order SPE2DX22D0010-SPE2D826FCC22
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,459.67 and is scheduled for completion by December 19, 2025. The contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 10mg, with a contract ceiling value of $2,071.44 and a completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with a ceiling value of $2,137.71. This competitively awarded, firm fixed-price delivery order was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Amphetamine Mix (AD) Extended Release capsules in 20 mg dosage. This competitively awarded, non-set-aside delivery order carries a firm fixed price ceiling value of $1,214.30, with an ultimate completion date of November 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,584.17 to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 20 mg, with a completion date of December 23, 2025. This is a firm fixed-price, non-set-aside delivery order issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules, 25mg, with a ceiling value of $4,993.24. This is a firm fixed price delivery order awarded on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract employs no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with a ceiling value of $1,055.37 and an ultimate completion date of October 1, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This firm fixed-price delivery order, valued at $3,079.41, represents a non-competitive set-aside contract and is scheduled for completion by January 2, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $4,408.02 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25 mg, with a completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military healthcare systems....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, non-set-aside contract has a ceiling value of $2,643.72 with a firm fixed price structure and an ultimate completion date of December 22, 2025. The pharmaceutical products will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCC22Delivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitive delivery order, valued at $2,555.08 with firm fixed pricing, will be completed by December 31, 2025, and represents a continuation of the government's pharmaceutical procurement efforts through established contract vehicles. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio encompasses a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast array of medical commodities to support military healthcare programs worldwide, with customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order for controlled substance medication reflects the company's role in fulfilling critical neurological and behavioral health pharmaceutical needs within the defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/29/25 |